Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
35.1M
-
Shares change
-
+6.54M
-
Total reported value, excl. options
-
$686M
-
Value change
-
+$88.7M
-
Put/Call ratio
-
0.9
-
Number of buys
-
70
-
Number of sells
-
-70
-
Price
-
$19.52
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q1 2016
206 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2016.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.1M shares
of 106M outstanding shares and own 33.26% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.83M shares), Point72 Asset Management, L.P. (2.96M shares), VANGUARD GROUP INC (2.94M shares), STATE STREET CORP (2.47M shares), FMR LLC (1.8M shares), BlackRock Fund Advisors (1.66M shares), CITADEL ADVISORS LLC (1.52M shares), Jefferies Group LLC (1.16M shares), venBio Select Advisor LLC (1.16M shares), and COLUMBIA WANGER ASSET MANAGEMENT LLC (1.12M shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.